Back Article

Amanat, F., Thapa, M., Lei, T., Ahmed, S.M.S., Adelsberg, D.C., Carreño, J.M.,Strohmeier, S., Schmitz, A.J., Zafar, S., Zhou, J.Q., Rijnink, W., Alshammary, H., Borcherding, N., Reiche, A.G., Srivastava, K., Sordillo, E.M., van Bakel, H., Turner, J.S., Bajic, G., Simon, V., Ellebedy, A.H., Krammer, F., 2021. Sars-cov-2 mrna vaccination induces functionally diverse antibodies to ntd, rbd, and s2. Cell 184, 3936-3948.e10.

Baum, A., Fulton, B.O., Wloga, E., Copin, R., Pascal, K.E., Russo, V., Giordano, S., Lanza, K., Negron, N., Ni, M., Wei, Y., Atwal, G.S., Murphy, A.J., Stahl, N., Yancopoulos, G.D., Kyratsous, C.A., 2020. Antibody cocktail to sars-cov-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science 369, 1014-1018.

Boyoglu-Barnum, S., Ellis, D., Gillespie, R.A., Hutchinson, G.B., Park, Y.J., Moin, S.M., Acton, O.J., Ravichandran, R., Murphy, M., Pettie, D., Matheson, N., Carter, L., Creanga, A., Watson, M.J., Kephart, S., Ataca, S., Vaile, J.R., Ueda, G., Crank, M.C., Stewart, L., Lee, K.K., Guttman, M., Baker, D., Mascola, J.R., Veesler, D., Graham, B.S., King, N.P., Kanekiyo, M., 2021. Quadrivalent influenza nanoparticle vaccines induce broad protection. Nature 592, 623-628.

Cai, Y., Zhang, J., Xiao, T., Peng, H., Sterling, S.M., Walsh Jr., R.M., Rawson, S., RitsVolloch, S., Chen, B., 2020. Distinct conformational states of sars-cov-2 spike protein. Science 369, 1586-1592.

Cao, Y., Wang, J., Jian, F., Xiao, T., Song, W., Yisimayi, A., Huang, W., Li, Q., Wang, P., An, R., Wang, J., Wang, Y., Niu, X., Yang, S., Liang, H., Sun, H., Li, T., Yu, Y., Cui, Q., Liu, S., Yang, X., Du, S., Zhang, Z., Hao, X., Shao, F., Jin, R., Wang, X., Xiao, J., Wang, Y., Xie, X.S., 2022a. Omicron escapes the majority of existing sars-cov-2 neutralizing antibodies. Nature 602, 657-663.

Cao, Y., Yisimayi, A., Jian, F., Song, W., Xiao, T., Wang, L., Du, S., Wang, J., Li, Q., Chen, X., Wang, P., Zhang, Z., Liu, P., An, R., Hao, X., Wang, Y., Wang, J., Feng, R., Sun, H., Zhao, L., Zhang, W., Zhao, D., Zheng, J., Yu, L., Li, C., Zhang, N., Wang, R., Niu, X., Yang, S., Song, X., Zheng, L., Li, Z., Gu, Q., Shao, F., Huang, W., Jin, R., Shen, Z., Wang, Y., Wang, X., Xiao, J., Xie, X.S., 2022b. Ba.2.12.1, ba.4 and ba.5 escape antibodies elicited by omicron infection. bioRxiv, 2022.2004.2030.489997.Preprint.

Cerutti, G., Guo, Y., Zhou, T., Gorman, J., Lee, M., Rapp, M., Reddem, E.R., Yu, J., Bahna, F., Bimela, J., Huang, Y., Katsamba, P.S., Liu, L., Nair, M.S., Rawi, R., Olia, A.S., Wang, P., Zhang, B., Chuang, G.Y., Ho, D.D., Sheng, Z., Kwong, P.D., Shapiro, L., 2021. Potent sars-cov-2 neutralizing antibodies directed against spike nterminal domain target a single supersite. Cell Host Microbe 29, 819-833 e817.

Crawford, K.H.D., Dingens, A.S., Eguia, R., Wolf, C.R., Wilcox, N., Logue, J.K., Shuey, K., Casto, A.M., Fiala, B., Wrenn, S., Pettie, D., King, N.P., Greninger, A.L., Chu, H.Y., Bloom, J.D., 2021. Dynamics of neutralizing antibody titers in the months after severe acute respiratory syndrome coronavirus 2 infection. J. Infect. Dis. 223, 197-205.

Dieterle, M.E., Haslwanter, D., Bortz 3rd, R.H., Wirchnianski, A.S., Lasso, G., Vergnolle, O., Abbasi, S.A., Fels, J.M., Laudermilch, E., Florez, C., Mengotto, A., Kimmel, D., Malonis, R.J., Georgiev, G., Quiroz, J., Barnhill, J., Pirofski, L.A., Daily, J.P., Dye, J.M., Lai, J.R., Herbert, A.S., Chandran, K., Jangra, R.K., 2020.A replication-competent vesicular stomatitis virus for studies of sars-cov-2 spikemediated cell entry and its inhibition. Cell Host Microbe 28, 486-496.e6.

Hansen, J., Baum, A., Pascal, K.E., Russo, V., Giordano, S., Wloga, E., Fulton, B.O., Yan, Y., Koon, K., Patel, K., Chung, K.M., Hermann, A., Ullman, E., Cruz, J., Rafique, A., Huang, T., Fairhurst, J., Libertiny, C., Malbec, M., Lee, W.Y., Welsh, R., Farr, G., Pennington, S., Deshpande, D., Cheng, J., Watty, A., Bouffard, P., Babb, R., Levenkova, N., Chen, C., Zhang, B., Romero Hernandez, A., Saotome, K., Zhou, Y., Franklin, M., Sivapalasingam, S., Lye, D.C., Weston, S., Logue, J., Haupt, R., Frieman, M., Chen, G., Olson, W., Murphy, A.J., Stahl, N., Yancopoulos, G.D., Kyratsous, C.A., 2020. Studies in humanized mice and convalescent humans yield a sars-cov-2 antibody cocktail. Science 369, 1010-1014.

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T.S., Herrler, G., Wu, N.H., Nitsche, A., Müller, M.A., Drosten, C., Pöhlmann, S., 2020. Sars-cov-2 cell entry depends on ace2 and tmprss2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271-280.e8.

Jackson, C.B., Farzan, M., Chen, B., Choe, H., 2022. Mechanisms of sars-cov-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23, 3-20.

Kanekiyo, M., Joyce, M.G., Gillespie, R.A., Gallagher, J.R., Andrews, S.F., Yassine, H.M., Wheatley, A.K., Fisher, B.E., Ambrozak, D.R., Creanga, A., Leung, K., Yang, E.S., Boyoglu-Barnum, S., Georgiev, I.S., Tsybovsky, Y., Prabhakaran, M.S., Andersen, H., Kong, W.P., Baxa, U., Zephir, K.L., Ledgerwood, J.E., Koup, R.A., Kwong, P.D., Harris, A.K., McDermott, A.B., Mascola, J.R., Graham, B.S., 2019. Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad b cell responses. Nat. Immunol. 20, 362-372.

Krammer, F., 2020. Sars-cov-2 vaccines in development. Nature 586, 516-527.

Li, M., Wang, H., Tian, L., Pang, Z., Yang, Q., Huang, T., Fan, J., Song, L., Tong, Y., Fan, H., 2022. Covid-19 vaccine development: milestones, lessons and prospects. Signal Transduct. Targeted Ther. 7, 146.

Li, W., Chen, Y., Prévost, J., Ullah, I., Lu, M., Gong, S.Y., Tauzin, A., Gasser, R., Vézina, D., Anand, S.P., Goyette, G., Chaterjee, D., Ding, S., Tolbert, W.D., Grunst, M.W., Bo, Y., Zhang, S., Richard, J., Zhou, F., Huang, R.K., Esser, L., Zeher, A., Cot ^ é, M., Kumar, P., Sodroski, J., Xia, D., Uchil, P.D., Pazgier, M., Finzi, A., Mothes, W., 2022. Structural basis and mode of action for two broadly neutralizing antibodies against sars-cov-2 emerging variants of concern. Cell Rep. 38, 110210.

Li, Y., Ma, M.L., Lei, Q., Wang, F., Hong, W., Lai, D.Y., Hou, H., Xu, Z.W., Zhang, B., Chen, H., Yu, C., Xue, J.B., Zheng, Y.X., Wang, X.N., Jiang, H.W., Zhang, H.N., Qi, H., Guo, S.J., Zhang, Y., Lin, X., Yao, Z., Wu, J., Sheng, H., Zhang, Y., Wei, H., Sun, Z., Fan, X., Tao, S.C., 2021. Linear epitope landscape of the sars-cov-2 spike protein constructed from 1,051 covid-19 patients. Cell Rep. 34, 108915.

Liu, L., Iketani, S., Guo, Y., Chan, J.F., Wang, M., Liu, L., Luo, Y., Chu, H., Huang, Y., Nair, M.S., Yu, J., Chik, K.K., Yuen, T.T., Yoon, C., To, K.K., Chen, H., Yin, M.T., Sobieszczyk, M.E., Huang, Y., Wang, H.H., Sheng, Z., Yuen, K.Y., Ho, D.D., 2022. Striking antibody evasion manifested by the omicron variant of sars-cov-2. Nature 602, 676-681.

Ma, H., Tseng, C.-T.K., Zong, H., Liao, Y., Ke, Y., Tang, H., Wang, L., Wang, Z., He, Y., Chang, Y., Wang, S., Drelich, A., Hsu, J., Tat, V., Yuan, Y., Wu, M., Liu, J., Yue, Y., Xu, W., Zhang, X., Wang, Z., Yang, L., Chen, H., Bian, Y., Zhang, B., Yin, H., Chen, Y., Zhang, E., Zhang, X., Gilly, J., Sun, T., Han, L., Xie, Y., Jiang, H., Zhu, J., 2022a. Efficient neutralization of sars-cov-2 omicron and other vocs by a broad spectrum antibody 8g3. bioRxiv, 2022.2002.2025.482049. Preprint.

Ma, H., Guo, Y., Tang, H., Tseng, C.-T.K., Wang, L., Zong, H., Wang, Z., He, Y., Chang, Y., Wang, S., Huang, H., Ke, Y., Yuan, Y., Wu, M., Zhang, Y., Drelich, A., Kempaiah, K.R., Peng, B.-H., Wang, A., Yang, K., Yin, H., Liu, J., Yue, Y., Xu, W., Zhu, S., Ji, T., Zhang, X., Wang, Z., Li, G., Liu, G., Song, J., Mu, L., Xiang, Z., Song, Z., Chen, H., Bian, Y., Zhang, B., Chen, H., Zhang, J., Liao, Y., Zhang, L., Yang, L., Chen, Y., Gilly, J., Xiao, X., Han, L., Jiang, H., Xie, Y., Zhou, Q., Zhu, J., 2022b. Broad ultrapotent neutralization of sars-cov-2 variants by monoclonal antibodies specific to the tip of rbd. Cell Discovery 8, 16.

McCallum, M., De Marco, A., Lempp, F.A., Tortorici, M.A., Pinto, D., Walls, A.C., Beltramello, M., Chen, A., Liu, Z., Zatta, F., Zepeda, S., di Iulio, J., Bowen, J.E., Montiel-Ruiz, M., Zhou, J., Rosen, L.E., Bianchi, S., Guarino, B., Fregni, C.S., Abdelnabi, R., Foo, S.C., Rothlauf, P.W., Bloyet, L.M., Benigni, F., Cameroni, E., Neyts, J., Riva, A., Snell, G., Telenti, A., Whelan, S.P.J., Virgin, H.W., Corti, D., Pizzuto, M.S., Veesler, D., 2021. N-terminal domain antigenic mapping reveals a site of vulnerability for sars-cov-2. Cell 184, 2332-2347.e16.

Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., Ferrin, T.E., 2004. Ucsf chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612.

Piccoli, L., Park, Y.J., Tortorici, M.A., Czudnochowski, N., Walls, A.C., Beltramello, M., Silacci-Fregni, C., Pinto, D., Rosen, L.E., Bowen, J.E., Acton, O.J., Jaconi, S., Guarino, B., Minola, A., Zatta, F., Sprugasci, N., Bassi, J., Peter, A., De Marco, A., Nix, J.C., Mele, F., Jovic, S., Rodriguez, B.F., Gupta, S.V., Jin, F., Piumatti, G., Lo Presti, G., Pellanda, A.F., Biggiogero, M., Tarkowski, M., Pizzuto, M.S., Cameroni, E., Havenar-Daughton, C., Smithey, M., Hong, D., Lepori, V., Albanese, E., Ceschi, A., Bernasconi, E., Elzi, L., Ferrari, P., Garzoni, C., Riva, A., Snell, G., Sallusto, F., Fink, K., Virgin, H.W., Lanzavecchia, A., Corti, D., Veesler, D., 2020. Mapping neutralizing and immunodominant sites on the sars-cov-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell 183, 1024-1042.e21.

Pinto, D., Sauer, M.M., Czudnochowski, N., Low, J.S., Tortorici, M.A., Housley, M.P., Noack, J., Walls, A.C., Bowen, J.E., Guarino, B., Rosen, L.E., di Iulio, J., Jerak, J., Kaiser, H., Islam, S., Jaconi, S., Sprugasci, N., Culap, K., Abdelnabi, R., Foo, C., Coelmont, L., Bartha, I., Bianchi, S., Silacci-Fregni, C., Bassi, J., Marzi, R., Vetti, E., Cassotta, A., Ceschi, A., Ferrari, P., Cippá, P.E., Giannini, O., Ceruti, S., Garzoni, C., Riva, A., Benigni, F., Cameroni, E., Piccoli, L., Pizzuto, M.S., Smithey, M., Hong, D., Telenti, A., Lempp, F.A., Neyts, J., Havenar-Daughton, C., Lanzavecchia, A., Sallusto, F., Snell, G., Virgin, H.W., Beltramello, M., Corti, D., Veesler, D., 2021. Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science 373, 1109-1116.

Planas, D., Saunders, N., Maes, P., Guivel-Benhassine, F., Planchais, C., Buchrieser, J., Bolland, W.H., Porrot, F., Staropoli, I., Lemoine, F., Péré, H., Veyer, D., Puech, J., Rodary, J., Baele, G., Dellicour, S., Raymenants, J., Gorissen, S., Geenen, C., Vanmechelen, B., Wawina-Bokalanga, T., Martí-Carreras, J., Cuypers, L., Séve, A., Hocqueloux, L., Prazuck, T., Rey, F.A., Simon-Loriere, E., Bruel, T., Mouquet, H., André, E., Schwartz, O., 2022. Considerable escape of sars-cov-2 omicron to antibody neutralization. Nature 602, 671-675.

Rockett, R., Basile, K., Maddocks, S., Fong, W., Agius, J.E., Johnson-Mackinnon, J., Arnott, A., Chandra, S., Gall, M., Draper, J., Martinez, E., Sim, E.M., Lee, C., Ngo, C., Ramsperger, M., Ginn, A.N., Wang, Q., Fennell, M., Ko, D., Lim, H.L., Gilroy, N., O'Sullivan, M.V.N., Chen, S.C., Kok, J., Dwyer, D.E., Sintchenko, V., 2022. Resistance mutations in sars-cov-2 delta variant after sotrovimab use. N. Engl. J. Med. 386, 1477-1479.

Sakharkar, M., Rappazzo, C.G., Wieland-Alter, W.F., Hsieh, C.L., Wrapp, D., Esterman, E.S., Kaku, C.I., Wec, A.Z., Geoghegan, J.C., McLellan, J.S., Connor, R.I., Wright, P.F., Walker, L.M., 2021. Prolonged evolution of the human b cell response to sars-cov-2 infection. Sci Immunol 6, 1-14.

Sauer, M.M., Tortorici, M.A., Park, Y.J., Walls, A.C., Homad, L., Acton, O.J., Bowen, J.E., Wang, C., Xiong, X., de van der Schueren, W., Quispe, J., Hoffstrom, B.G., Bosch, B.J., McGuire, A.T., Veesler, D., 2021. Structural basis for broad coronavirus neutralization. Nat. Struct. Mol. Biol. 28, 478-486.

Shah, P., Canziani, G.A., Carter, E.P., Chaiken, I., 2021. The case for s2: the potential benefits of the s2 subunit of the sars-cov-2 spike protein as an immunogen in fighting the covid-19 pandemic. Front. Immunol. 12, 637-651.

Starr, T.N., Greaney, A.J., Addetia, A., Hannon, W.W., Choudhary, M.C., Dingens, A.S., Li, J.Z., Bloom, J.D., 2021. Prospective mapping of viral mutations that escape antibodies used to treat covid-19. Science 371, 850-854.

Tang, H., Ke, Y., Wang, L., Wu, M., Sun, T., Zhu, J., 2022. Recombinant decoy exhibits broad protection against omicron and resistance potential to future variants.Pharmaceuticals 15, 1-18.

Tao, K., Tzou, P.L., Nouhin, J., Gupta, R.K., de Oliveira, T., Kosakovsky Pond, S.L., Fera, D., Shafer, R.W., 2021. The biological and clinical significance of emerging sarscov-2 variants. Nat. Rev. Genet. 22, 757-773.

Tortorici, M.A., Veesler, D., 2019. Structural insights into coronavirus entry. Adv. Virus Res. 105, 93-116.

Tortorici, M.A., Czudnochowski, N., Starr, T.N., Marzi, R., Walls, A.C., Zatta, F., Bowen, J.E., Jaconi, S., Di Iulio, J., Wang, Z., De Marco, A., Zepeda, S.K., Pinto, D., Liu, Z., Beltramello, M., Bartha, I., Housley, M.P., Lempp, F.A., Rosen, L.E., Dellota Jr., E., Kaiser, H., Montiel-Ruiz, M., Zhou, J., Addetia, A., Guarino, B., Culap, K., Sprugasci, N., Saliba, C., Vetti, E., Giacchetto-Sasselli, I., Fregni, C.S., Abdelnabi, R., Foo, S.C., Havenar-Daughton, C., Schmid, M.A., Benigni, F., Cameroni, E., Neyts, J., Telenti, A., Virgin, H.W., Whelan, S.P.J., Snell, G., Bloom, J.D., Corti, D., Veesler, D., Pizzuto, M.S., 2021. Broad sarbecovirus neutralization by a human monoclonal antibody. Nature 597, 103-108.

Ullah, I., Prévost, J., Ladinsky, M.S., Stone, H., Lu, M., Anand, S.P., BeaudoinBussiéres, G., Symmes, K., Benlarbi, M., Ding, S., Gasser, R., Fink, C., Chen, Y., Tauzin, A., Goyette, G., Bourassa, C., Medjahed, H., Mack, M., Chung, K., Wilen, C.B., Dekaban, G.A., Dikeakos, J.D., Bruce, E.A., Kaufmann, D.E., Stamatatos, L., McGuire, A.T., Richard, J., Pazgier, M., Bjorkman, P.J., Mothes, W., Finzi, A., Kumar, P., Uchil, P.D., 2021. Live imaging of sars-cov-2 infection in mice reveals that neutralizing antibodies require fc function for optimal efficacy. Immunity 54, 2143-2158.e15.

Viana, R., Moyo, S., Amoako, D.G., Tegally, H., Scheepers, C., Althaus, C.L., Anyaneji, U.J., Bester, P.A., Boni, M.F., Chand, M., Choga, W.T., Colquhoun, R., Davids, M., Deforche, K., Doolabh, D., du Plessis, L., Engelbrecht, S., Everatt, J., Giandhari, J., Giovanetti, M., Hardie, D., Hill, V., Hsiao, N.Y., Iranzadeh, A., Ismail, A., Joseph, C., Joseph, R., Koopile, L., Kosakovsky Pond, S.L., Kraemer, M.U.G., Kuate-Lere, L., Laguda-Akingba, O., Lesetedi-Mafoko, O., Lessells, R.J., Lockman, S., Lucaci, A.G., Maharaj, A., Mahlangu, B., Maponga, T., Mahlakwane, K., Makatini, Z., Marais, G., Maruapula, D., Masupu, K., Matshaba, M., Mayaphi, S., Mbhele, N., Mbulawa, M.B., Mendes, A., Mlisana, K., Mnguni, A., Mohale, T., Moir, M., Moruisi, K., Mosepele, M., Motsatsi, G., Motswaledi, M.S., Mphoyakgosi, T., Msomi, N., Mwangi, P.N., Naidoo, Y., Ntuli, N., Nyaga, M., Olubayo, L., Pillay, S., Radibe, B., Ramphal, Y., Ramphal, U., San, J.E., Scott, L., Shapiro, R., Singh, L., Smith-Lawrence, P., Stevens, W., Strydom, A., Subramoney, K., Tebeila, N., Tshiabuila, D., Tsui, J., van Wyk, S., Weaver, S., Wibmer, C.K., Wilkinson, E., Wolter, N., Zarebski, A.E., Zuze, B., Goedhals, D., Preiser, W., Treurnicht, F., Venter, M., Williamson, C., Pybus, O.G., Bhiman, J., Glass, A., Martin, D.P., Rambaut, A., Gaseitsiwe, S., von Gottberg, A., de Oliveira, T., 2022.Rapid epidemic expansion of the sars-cov-2 omicron variant in southern africa. Nature 603, 679-686.

Voss, W.N., Hou, Y.J., Johnson, N.V., Delidakis, G., Kim, J.E., Javanmardi, K., Horton, A.P., Bartzoka, F., Paresi, C.J., Tanno, Y., Chou, C.W., Abbasi, S.A., Pickens, W., George, K., Boutz, D.R., Towers, D.M., McDaniel, J.R., Billick, D., Goike, J., Rowe, L., Batra, D., Pohl, J., Lee, J., Gangappa, S., Sambhara, S., Gadush, M., Wang, N., Person, M.D., Iverson, B.L., Gollihar, J.D., Dye, J.M., Herbert, A.S., Finkelstein, I.J., Baric, R.S., McLellan, J.S., Georgiou, G., Lavinder, J.J., Ippolito, G.C., 2021. Prevalent, protective, and convergent igg recognition of sarscov-2 non-rbd spike epitopes. Science 372, 1108-1112.

Wall, E.C., Wu, M., Harvey, R., Kelly, G., Warchal, S., Sawyer, C., Daniels, R., Hobson, P., Hatipoglu, E., Ngai, Y., Hussain, S., Nicod, J., Goldstone, R., Ambrose, K., Hindmarsh, S., Beale, R., Riddell, A., Gamblin, S., Howell, M., Kassiotis, G., Libri, V., Williams, B., Swanton, C., Gandhi, S., Bauer, D.L., 2021. Neutralising antibody activity against sars-cov-2 vocs b.1.617.2 and b.1.351 by bnt162b2 vaccination. Lancet 397, 2331-2333.

Walls, A.C., Park, Y.J., Tortorici, M.A., Wall, A., McGuire, A.T., Veesler, D., 2020a. Structure, function, and antigenicity of the sars-cov-2 spike glycoprotein. Cell 181, 281-292 e286.

Walls, A.C., Fiala, B., Schäfer, A., Wrenn, S., Pham, M.N., Murphy, M., Tse, L.V., Shehata, L., O'Connor, M.A., Chen, C., Navarro, M.J., Miranda, M.C., Pettie, D., Ravichandran, R., Kraft, J.C., Ogohara, C., Palser, A., Chalk, S., Lee, E.C., Guerriero, K., Kepl, E., Chow, C.M., Sydeman, C., Hodge, E.A., Brown, B., Fuller, J.T., Dinnon 3rd, K.H., Gralinski, L.E., Leist, S.R., Gully, K.L., Lewis, T.B., Guttman, M., Chu, H.Y., Lee, K.K., Fuller, D.H., Baric, R.S., Kellam, P., Carter, L., Pepper, M., Sheahan, T.P., Veesler, D., King, N.P., 2020b. Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for sars-cov-2. Cell 183, 1367-1382 e1317.

Wang, L., Zhou, T., Zhang, Y., Yang, E.S., Schramm, C.A., Shi, W., Pegu, A., Oloniniyi, O.K., Henry, A.R., Darko, S., Narpala, S.R., Hatcher, C., Martinez, D.R., Tsybovsky, Y., Phung, E., Abiona, O.M., Antia, A., Cale, E.M., Chang, L.A., Choe, M., Corbett, K.S., Davis, R.L., DiPiazza, A.T., Gordon, I.J., Hait, S.H., Hermanus, T., Kgagudi, P., Laboune, F., Leung, K., Liu, T., Mason, R.D., Nazzari, A.F., Novik, L., O'Connell, S., O'Dell, S., Olia, A.S., Schmidt, S.D., Stephens, T., Stringham, C.D., Talana, C.A., Teng, I.T., Wagner, D.A., Widge, A.T., Zhang, B., Roederer, M., Ledgerwood, J.E., Ruckwardt, T.J., Gaudinski, M.R., Moore, P.L., Doria-Rose, N.A., Baric, R.S., Graham, B.S., McDermott, A.B., Douek, D.C., Kwong, P.D., Mascola, J.R., Sullivan, N.J., Misasi, J., 2021. Ultrapotent antibodies against diverse and highly transmissible sars-cov-2 variants. Science 373, 1-14.

Wang, P., Nair, M.S., Liu, L., Iketani, S., Luo, Y., Guo, Y., Wang, M., Yu, J., Zhang, B., Kwong, P.D., Graham, B.S., Mascola, J.R., Chang, J.Y., Yin, M.T., Sobieszczyk, M., Kyratsous, C.A., Shapiro, L., Sheng, Z., Huang, Y., Ho, D.D., 2021. Antibody resistance of sars-cov-2 variants b.1.351 and b.1.1.7. Nature 593, 130-135.

Whelan, S.P., Ball, L.A., Barr, J.N., Wertz, G.T., 1995. Efficient recovery of infectious vesicular stomatitis virus entirely from cdna clones. Proc. Natl. Acad. Sci. U. S. A. 92, 8388-8392.

Woo, H., Park, S.J., Choi, Y.K., Park, T., Tanveer, M., Cao, Y., Kern, N.R., Lee, J., Yeom, M.S., Croll, T.I., Seok, C., Im, W., 2020. Developing a fully glycosylated fulllength sars-cov-2 spike protein model in a viral membrane. J. Phys. Chem. B 124, 7128-7137.

Yu, X., Wei, D., Xu, W., Liu, C., Guo, W., Li, X., Tan, W., Liu, L., Zhang, X., Qu, J., Yang, Z., Chen, E., 2022. Neutralizing activity of bbibp-corv vaccine-elicited sera against beta, delta and other sars-cov-2 variants of concern. Nat. Commun. 13, 1788.

Zhou, P., Yuan, M., Song, G., Beutler, N., Shaabani, N., Huang, D., He, W.T., Zhu, X., Callaghan, S., Yong, P., Anzanello, F., Peng, L., Ricketts, J., Parren, M., Garcia, E., Rawlings, S.A., Smith, D.M., Nemazee, D., Teijaro, J.R., Rogers, T.F., Wilson, I.A., Burton, D.R., Andrabi, R., 2022. A human antibody reveals a conserved site on betacoronavirus spike proteins and confers protection against sars-cov-2 infection. Sci.Transl. Med. 14, eabi9215.